The post SEC makes groundbreaking move in XRP ETF approval process appeared on BitcoinEthereumNews.com. The Securities Exchange Commission (SEC) has taken a major step that could accelerate the launch of spot exchange-traded funds (ETFs) tied to several major cryptocurrencies, including XRP. According to cryptocurrency journalist Eleanor Terrett, the SEC has asked issuers to withdraw their existing 19b-4 filings following the approval of new generic listing standards. Withdrawals could begin as early as this week, she said in an X post on September 29.  Besides XRP, other affected cryptocurrencies include Litecoin (LTC), Solana (SOL), Cardano (ADA), and Dogecoin (DOGE). More context for those asking whether withdrawal is a bad thing: the short answer is no. The long answer: when the @SECGov approved the generic listing standards two weeks ago, it eliminated the need for exchanges to file 19b-4 forms to list individual token ETFs, simplifying and… https://t.co/byHmCkMti1 — Eleanor Terrett (@EleanorTerrett) September 29, 2025 Notably, Terrett emphasized that the move is not a setback. In this case, the SEC’s generic listing standards eliminate the need for individual 19b-4 filings for token-based ETFs, simplifying and speeding up the approval process.  Under the new rules, as long as a cryptocurrency meets the established criteria, an ETF can be approved with just an S-1 filing. This means the SEC could approve one or multiple ETFs at any time, streamlining access for investors. SEC ETF decisions  The decision comes as the SEC is expected to make rulings on several altcoin ETFs later in October, increasing the likelihood that assets like XRP could receive approval.  Market participants are anticipating a significant October for ETFs, which could lead to substantial inflows into altcoins from institutional investors. The SEC will decide on 16 cryptocurrency ETFs, with final deadlines scattered throughout the month.  Canary’s Litecoin ETF is up first on October 2, followed by Grayscale’s Solana and Litecoin trust conversions on October 10,… The post SEC makes groundbreaking move in XRP ETF approval process appeared on BitcoinEthereumNews.com. The Securities Exchange Commission (SEC) has taken a major step that could accelerate the launch of spot exchange-traded funds (ETFs) tied to several major cryptocurrencies, including XRP. According to cryptocurrency journalist Eleanor Terrett, the SEC has asked issuers to withdraw their existing 19b-4 filings following the approval of new generic listing standards. Withdrawals could begin as early as this week, she said in an X post on September 29.  Besides XRP, other affected cryptocurrencies include Litecoin (LTC), Solana (SOL), Cardano (ADA), and Dogecoin (DOGE). More context for those asking whether withdrawal is a bad thing: the short answer is no. The long answer: when the @SECGov approved the generic listing standards two weeks ago, it eliminated the need for exchanges to file 19b-4 forms to list individual token ETFs, simplifying and… https://t.co/byHmCkMti1 — Eleanor Terrett (@EleanorTerrett) September 29, 2025 Notably, Terrett emphasized that the move is not a setback. In this case, the SEC’s generic listing standards eliminate the need for individual 19b-4 filings for token-based ETFs, simplifying and speeding up the approval process.  Under the new rules, as long as a cryptocurrency meets the established criteria, an ETF can be approved with just an S-1 filing. This means the SEC could approve one or multiple ETFs at any time, streamlining access for investors. SEC ETF decisions  The decision comes as the SEC is expected to make rulings on several altcoin ETFs later in October, increasing the likelihood that assets like XRP could receive approval.  Market participants are anticipating a significant October for ETFs, which could lead to substantial inflows into altcoins from institutional investors. The SEC will decide on 16 cryptocurrency ETFs, with final deadlines scattered throughout the month.  Canary’s Litecoin ETF is up first on October 2, followed by Grayscale’s Solana and Litecoin trust conversions on October 10,…

SEC makes groundbreaking move in XRP ETF approval process

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The Securities Exchange Commission (SEC) has taken a major step that could accelerate the launch of spot exchange-traded funds (ETFs) tied to several major cryptocurrencies, including XRP.

According to cryptocurrency journalist Eleanor Terrett, the SEC has asked issuers to withdraw their existing 19b-4 filings following the approval of new generic listing standards. Withdrawals could begin as early as this week, she said in an X post on September 29. 

Besides XRP, other affected cryptocurrencies include Litecoin (LTC), Solana (SOL), Cardano (ADA), and Dogecoin (DOGE).

Notably, Terrett emphasized that the move is not a setback. In this case, the SEC’s generic listing standards eliminate the need for individual 19b-4 filings for token-based ETFs, simplifying and speeding up the approval process. 

Under the new rules, as long as a cryptocurrency meets the established criteria, an ETF can be approved with just an S-1 filing. This means the SEC could approve one or multiple ETFs at any time, streamlining access for investors.

SEC ETF decisions 

The decision comes as the SEC is expected to make rulings on several altcoin ETFs later in October, increasing the likelihood that assets like XRP could receive approval. 

Market participants are anticipating a significant October for ETFs, which could lead to substantial inflows into altcoins from institutional investors.

The SEC will decide on 16 cryptocurrency ETFs, with final deadlines scattered throughout the month. 

Canary’s Litecoin ETF is up first on October 2, followed by Grayscale’s Solana and Litecoin trust conversions on October 10, and WisdomTree’s XRP fund on October 24. 

While decisions could happen at any time before these deadlines, analysts see the approvals as a potential catalyst for a renewed altcoin rally.

Featured image via Shutterstock

Source: https://finbold.com/sec-makes-groundbreaking-move-in-xrp-etf-approval-process/

Market Opportunity
Movement Logo
Movement Price(MOVE)
$0.02257
$0.02257$0.02257
+0.08%
USD
Movement (MOVE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

a16z Targets $2 Billion Crypto Fund as Venture Capital Eyes Blockchain Recovery

a16z Targets $2 Billion Crypto Fund as Venture Capital Eyes Blockchain Recovery

Andreessen Horowitz’s crypto division, a16z crypto, is reportedly running $2 billion for its fifth crypto investment fund. This move from a firm is happening when
Share
Thenewscrypto2026/03/05 20:29
ArtGis Finance Partners with MetaXR to Expand its DeFi Offerings in the Metaverse

ArtGis Finance Partners with MetaXR to Expand its DeFi Offerings in the Metaverse

By using this collaboration, ArtGis utilizes MetaXR’s infrastructure to widen access to its assets and enable its customers to interact with the metaverse.
Share
Blockchainreporter2025/09/18 00:07
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11